Labiana Health (XMAD:LAB) Receivables Turnover : 2.80 (As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Labiana Health's Revenue for the six months ended in Dec. 2022 was €28.79 Mil. Labiana Health's average Accounts Receivable for the six months ended in Dec. 2022 was €10.28 Mil. Hence, Labiana Health's Receivables Turnover for the six months ended in Dec. 2022 was 2.80.

Labiana Health Receivables Turnover Historical Data

The historical data trend for Labiana Health's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Receivables Turnover Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

Receivables Turnover

5.52

6.19

6.92

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
Receivables Turnover	-	-	2.95	2.80

Competitive Comparison of Labiana Health's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labiana Health's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Labiana Health's Receivables Turnover falls into.

Labiana Health Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Labiana Health's Receivables Turnover for the fiscal year that ended in Dec. 2022 is calculated as

	Receivables Turnover (A: Dec. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2022 )	/ (	(Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )
=	57.848	/ (	(7.934	+	8.778)	/	2 )
=	57.848	/	8.356
=	6.92

Labiana Health's Receivables Turnover for the quarter that ended in Dec. 2022 is calculated as

	Receivables Turnover (Q: Dec. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2022 )	/ (	(Accounts Receivable (Q: Jun. 2022 )	+	Accounts Receivable (Q: Dec. 2022 ))	/	count )
=	28.787	/ (	(11.781	+	8.778)	/	2 )
=	28.787	/	10.2795
=	2.80

Labiana Health (XMAD:LAB) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Labiana Health Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Labiana Health's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Receivables Turnover

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.